Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus

• FUJIMURA Shigeru

  Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University

• FUSE Katsuhiro

  Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University

• TAKANE Hidenari

  Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University

• NAKANO Yoshihisa

  Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University

• GOMI Kazunori

  Department of Respiratory Oncology and Molecular Medicine, Tohoku University School of Medicine

• KIKUCHI Toshiaki

  Department of Respiratory Oncology and Molecular Medicine, Tohoku University School of Medicine

• WATANABE Akira

  Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University

収録刊行物

• Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 17 (1), 30-33, 2011-02-01

キーワード

• Generic drug
• Teicoplanin
• AUC
• PK-PD

詳細情報

• CRID: 1570291226262600832
• NII論文ID: 10027816661
• NII書誌ID: AA11057978
• ISSN: 1341321X
• Web Site: https://search.jamas.or.jp/link/ui/2011303610
• 本文言語コード: en
• データソース種別:
  • CiNii Articles